Essential fatty acid supplementation in tardive dyskinesia
- PMID: 3013033
- DOI: 10.1176/ajp.143.7.912
Essential fatty acid supplementation in tardive dyskinesia
Abstract
Preclinical and clinical observations suggest that enhancement of prostaglandin activity inhibits catecholamine release and may have antidyskinetic effects. A double-blind therapeutic trial with prostaglandin precursor essential fatty acids was conducted in 16 patients with tardive dyskinesia. No beneficial effects were seen.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources